Literature DB >> 31219344

Data Sets for the Reporting of Tumors of the Central Nervous System: Recommendations From The International Collaboration on Cancer Reporting.

David N Louis1, Pieter Wesseling1, Sebastian Brandner1, Daniel J Brat1, David W Ellison1, Felice Giangaspero1, Eyas M Hattab1, Cynthia Hawkins1, Meagan J Judge1, Bette Kleinschmidt-DeMasters1, Takashi Komori1, Catriona McLean1, Werner Paulus1, Arie Perry1, Guido Reifenberger1, Michael Weller1, Brian Rous1.   

Abstract

CONTEXT.—: Standards for pathology reporting of cancer are foundational to national and international benchmarking, epidemiology, and clinical trials, with international standards for pathology reporting of cancer being undertaken through the International Collaboration on Cancer Reporting (ICCR). OBJECTIVE.—: To develop standardized templates for brain tumor diagnostic pathology reporting. DESIGN.—: As a response to the 2016 updated 4th edition of the WHO (World Health Organization) Classification of Tumours of the Central Nervous System (2016 CNS WHO), an expert ICCR committee developed data sets to facilitate reporting of brain tumors that are classified histologically and molecularly by the 2016 CNS WHO; as such, this represents the first combined histologic and molecular ICCR data set, and required a novel approach with 3 highly related data sets that should be used in an integrated manner. RESULTS.—: The current article and accompanying ICCR Web site describe reporting data sets for central nervous system tumors in the hope that they provide easy-to-use and highly reproducible means to issue diagnostic reports in consort with the 2016 CNS WHO. CONCLUSIONS.—: The consistent use of these templates will undoubtedly prove useful for patient care, clinical trials, epidemiologic studies, and monitoring of neuro-oncologic care around the world.

Entities:  

Year:  2019        PMID: 31219344     DOI: 10.5858/arpa.2018-0565-OA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  5 in total

1.  High-grade gliomas in adolescents and young adults reveal histomolecular differences vis-à-vis their adult and pediatric counterparts.

Authors:  Maura Massimino; Felice Giangaspero
Journal:  Neuro Oncol       Date:  2020-08-17       Impact factor: 12.300

Review 2.  2021 WHO classification of tumours of the central nervous system: a review for the neuroradiologist.

Authors:  Cillian McNamara; Kshitij Mankad; Stefanie Thust; Luke Dixon; Clara Limback-Stanic; Felice D'Arco; Thomas S Jacques; Ulrike Löbel
Journal:  Neuroradiology       Date:  2022-07-22       Impact factor: 2.995

Review 3.  Grading of adult diffuse gliomas according to the 2021 WHO Classification of Tumors of the Central Nervous System.

Authors:  Takashi Komori
Journal:  Lab Invest       Date:  2021-09-09       Impact factor: 5.662

4.  Cytotoxic effects and tolerability of gemcitabine and axitinib in a xenograft model for c-myc amplified medulloblastoma.

Authors:  Andreas Beilhack; Matthias Wölfl; Stefanie Schwinn; Zeinab Mokhtari; Sina Thusek; Theresa Schneider; Anna-Leena Sirén; Nicola Tiemeyer; Ignazio Caruana; Evelina Miele; Paul G Schlegel
Journal:  Sci Rep       Date:  2021-07-07       Impact factor: 4.379

Review 5.  The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Pieter Wesseling; Daniel J Brat; Ian A Cree; Dominique Figarella-Branger; Cynthia Hawkins; H K Ng; Stefan M Pfister; Guido Reifenberger; Riccardo Soffietti; Andreas von Deimling; David W Ellison
Journal:  Neuro Oncol       Date:  2021-08-02       Impact factor: 13.029

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.